Total weakness of the left foot in patients with end-stage heart failure is caused by insufficient cardiac perfusion and circulatory failure, and diuresis, cardiotonic, and vasodilatation are carried out mainly to improve clinical symptoms.
Heart failure patients with right heart failure will appear in the physical circulation of the stasis, mainly due to ventricular systolic dysfunction, cardiac output reduction caused by the systemic venous blood circulation reflux is impeded, resulting in lower limb edema, loss of appetite, numbness and weakness of the limbs. Mainly through cardiotonic, diuretic, vasodilator, treatment of the primary disease-oriented, to achieve the purpose of alleviating the symptoms.
Clinically, it is common to use p-acetyl furfuryl glycoside, which plays the role of cardiotonic; the application of nitrate drugs such as nitroglycerin, sodium nitroprusside dilates blood vessels and reduces the cardiac load; diuretic drugs are often chosen to furosemide, torasemide, etc., which promotes the circulation of body fluids, improves the phenomenon of edema, and alleviates the weakness of the left foot with total numbness. If the end-stage heart failure is serious, heart transplantation can be performed according to the patient’s condition.
End-stage heart failure patients left foot weakness, the main treatment is still based on the treatment of the primary disease, need to be carried out under the guidance of a professional doctor.